Top 10 Companies Leading the Grating-Coupled Interferometry Market
According to a newly published market research report by 24LifeSciences, global Grating-Coupled Interferometry (GCI) market was valued at USD 57.7 million in 2023 and is projected to reach USD 132 million by 2030, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025–2030.
Grating-Coupled Interferometry (GCI) is a sophisticated chip-based label-free biosensor technology renowned for its exceptional sensitivity and high signal-to-noise ratio, which is revolutionizing how researchers study molecular interactions. This breakthrough technology stands apart from traditional fluorescence and immunological label-dependent techniques by delivering comprehensive data on binding presence, specificity, affinity, and kinetic constantsall without requiring complex sample preparation. Its ability to work with crude biological samples makes it particularly valuable for accelerating drug discovery pipelines and providing more physiologically relevant data in near-native conditions.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3783/grating-coupled-interferometry-gci--global-outlook-and-market
According to a newly published market research report by 24LifeSciences, global Grating-Coupled Interferometry (GCI) market was valued at USD 57.7 million in 2023 and is projected to reach USD 132 million by 2030, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025–2030.
Grating-Coupled Interferometry (GCI) is a sophisticated chip-based label-free biosensor technology renowned for its exceptional sensitivity and high signal-to-noise ratio, which is revolutionizing how researchers study molecular interactions. This breakthrough technology stands apart from traditional fluorescence and immunological label-dependent techniques by delivering comprehensive data on binding presence, specificity, affinity, and kinetic constantsall without requiring complex sample preparation. Its ability to work with crude biological samples makes it particularly valuable for accelerating drug discovery pipelines and providing more physiologically relevant data in near-native conditions.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3783/grating-coupled-interferometry-gci--global-outlook-and-market
Top 10 Companies Leading the Grating-Coupled Interferometry Market
According to a newly published market research report by 24LifeSciences, global Grating-Coupled Interferometry (GCI) market was valued at USD 57.7 million in 2023 and is projected to reach USD 132 million by 2030, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025–2030.
Grating-Coupled Interferometry (GCI) is a sophisticated chip-based label-free biosensor technology renowned for its exceptional sensitivity and high signal-to-noise ratio, which is revolutionizing how researchers study molecular interactions. This breakthrough technology stands apart from traditional fluorescence and immunological label-dependent techniques by delivering comprehensive data on binding presence, specificity, affinity, and kinetic constantsall without requiring complex sample preparation. Its ability to work with crude biological samples makes it particularly valuable for accelerating drug discovery pipelines and providing more physiologically relevant data in near-native conditions.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3783/grating-coupled-interferometry-gci--global-outlook-and-market
0 Reacties
0 aandelen
82 Views
0 voorbeeld